KedouBC (科斗脑机)

KedouBC operates in neurotechnology, with an emphasis on brain-computer interface applications and electrophysiology tools for research and clinical settings. Its offering spans hardware, software, implanted neural microelectrodes, stimulation systems, and customized technical services. This breadth distinguishes its described position from a profile centered on a single electrode or acquisition product: customers can find multiple components of an electrophysiology workflow within its portfolio, including in vivo training and technical support. The described products address research and clinical applications, rather than establishing a particular approved therapeutic or consumer use. Its competitive position is best characterized as a broad specialist supplier of neural interfaces and electrophysiology equipment, with implanted microelectrodes as a core focus and a product range extending into acquisition, stimulation, wireless systems, and technical services.

KedouBC was founded in 2016 and has developed a portfolio spanning implanted neural microelectrodes, electrophysiology acquisition and stimulation systems, software, and customized technical services. That combination suggests growth from a core research-hardware focus toward a broader set of tools and support for research and clinical applications. The company describes more than 40 types of independently developed microelectrodes and related devices, and says its products have been used by more than 1,000 organizations; dates for these milestones are unavailable, so their pace of growth cannot be calculated. Collaboration with Tsinghua University and Southern University of Science and Technology, alongside internships for Tsinghua students, provides a signal of continuing academic engagement and talent development. As a result, the evidence supports a long-running product-development trajectory and research ecosystem ties, but does not establish recent acceleration, hiring scale, or revenue growth. Tracking future dated product announcements and quantified adoption would clarify whether the company is expanding beyond its established research-tool base.